EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative Study

Mike Wenzel, Arjun Nathan iD, Marcio Covas Moschovas, Christian Wagner, Giorgio Calleris iD, Fabrizio Di Maida iD, Juan Gomez Rivas, Carlo Andrea Bravi, Ruben De Groote, Federico Piramide, Filippo Turri, Keith Kowalczyk und 18 weitere

The Prostate · 2025-10 · 85 (14) · 1332-1341

DOI: 10.1002/pros.70020 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Prostate, online erschienen am 23.07.2025. Verfasst von Mike Wenzel und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Prostatectomy, Salvage Therapy, Prostatic Neoplasms, Robotic Surgical Procedures. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mike Wenzel is supported by a Scholarship of the Mildred-Scheel Nachwuchszentrum Frankfurt for the EPIC-REAP project (Enhancing Prostate cancer care In Germany….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate surgical and cancer‐control outcome differences in robotic salvage radical prostatectomy (s‐RARP) patients after primary prostate cancer treatment with radiation (RT) versus focal therapy (FT).

Methods

The Junior ERUS/Young Academic Urologist Working Group Robotics in Urology conducted a multicentric project to investigate biochemical recurrence‐free (BCR), metastases‐free (MFS) and overall survival outcomes in s‐RARP patients primarily treated with RT versus FT.

Results

Overall, 439 s‐RARP patients qualified for analyses, of which 54% initially received RT with a median time interval between primary cancer treatment and s‐RARP of 48 months. Patients with RT more frequently exhibited unfavorable oncological characteristics before s‐RARP (PSA, ISUP score), as well as pathological ISUP score (all ≤ 0.01), relative to FT patients. No differences in postoperative complications were observed ( p > 0.9). In BCR‐free analyses, no significant differences between RT and FT were observed (hazard ratio [HR]: 1.30, p = 0.2). In MFS and OS analyses, patients with RT harbored a higher risk of metastases (HR: 10.1, p < 0.001) and death (HR: 5.1, p = 0.02), relative to FT s‐RARP patients, but not after multivariable adjustment. In subgroup analyses of 201 FT patients, 80% received high‐intensified focused ultrasound (HIFU). No difference in BCR‐free survival was observed for HIFU‐ versus non‐HIFU s‐RARP patients ( p = 0.9).

Conclusions

Important differences in tumor characteristics between RT versus FT s‐RARP patients exist. These baseline differences translate into unfavorable short‐term MFS‐ and OS outcomes for RT s‐RARP patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomySalvage TherapyProstatic NeoplasmsRobotic Surgical ProceduresHumansMaleAgedMiddle AgedTreatment OutcomeDisease-Free Survival

Stichwörter der Autor:innen

BCRMFSSRARPbrachytherapyrecurrent prostate cancer

Autor:innen und Institutionen

  • Department of Urology, Goethe University Hospital Frankfurt, Frankfurt am Main, Germany.
  • University College London Hospitals NHS Foundation Trust, London, UK.
  • AdventHealth Global Robotics Institute, Celebration, Florida, USA.
  • Prostate Center Northwest, Department of Urology, Pediatric Urology and Uro Oncology, St. Antonius-Hospital, Gronau, Germany.
  • Urology Clinic, Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy.
  • Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.

ORCID-Profile: Arjun Nathan, Giorgio Calleris, Fabrizio Di Maida, Edward Lambert, Gabriele Sorce

Förderung

  • Mike Wenzel is supported by a Scholarship of the Mildred-Scheel Nachwuchszentrum Frankfurt for the EPIC-REAP project (Enhancing Prostate cancer care In Germany…

Zitieren

APA

Wenzel, M., Nathan, A., Covas Moschovas, M., Wagner, C., Calleris, G., Di Maida, F., Gomez Rivas, J., Bravi, C. A., De Groote, R., Piramide, F., Turri, F., Kowalczyk, K., Würnschimmel, C., Sharma, G., Andras, I., Lambert, E., Liakos, N., Darlington, D., Paciotti, M., …, & Larcher, A. (2025). Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative Study. The Prostate, 85(14), 1332-1341. https://doi.org/10.1002/pros.70020

Vancouver

Wenzel M, Nathan A, Covas Moschovas M, Wagner C, Calleris G, Di Maida F, et al. Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative Study. The Prostate. 2025;85(14):1332-1341. doi:10.1002/pros.70020

BibTeX
@article{Wenzel2025,
  author = {Wenzel, Mike and Nathan, Arjun and Covas Moschovas, Marcio and Wagner, Christian and Calleris, Giorgio and Di Maida, Fabrizio and Gomez Rivas, Juan and Bravi, Carlo Andrea and De Groote, Ruben and Piramide, Federico and Turri, Filippo and Kowalczyk, Keith and Würnschimmel, Christoph and Sharma, Gopal and Andras, Iulia and Lambert, Edward and Liakos, Nikolaos and Darlington, Danny and Paciotti, Marco and Sorce, Gabriele and Mandel, Philipp and Galfano, Antonio and Nathan, Senthil and Marra, Giancarlo and Dell'Oglio, Paolo and Mottrie, Alexandre and Chun, Felix K H and Patel, Vipul and Breda, Alberto and Larcher, Alessandro},
  title = {Oncological Outcomes After Robotic Salvage Radical Prostatectomy in Patients Primarily Treated With Focal Versus Radiation Therapy: A Junior ERUS/YAU Collaborative Study},
  journal = {The Prostate},
  year = {2025},
  volume = {85},
  number = {14},
  pages = {1332--1341},
  doi = {10.1002/pros.70020}
}
Kostenlos starten →